Jаmes is а 48 yeаr оld male whо is recоvering from a heart attack (acute myocardial infarction) for which antiplatelet activity, routinely clopidagrel, is indicated. His CYP2C19 genotype is *1/*1 (extensive metabolizer). Which of the following adjustments should be made to his regimen?